Blood Assurance Inc

Form 483 issued February 17, 2026 · Tullahoma, Tennessee

Inspection
Feb 17, 2026
Investigator
Cody D. Rickman
Observations
1
Pages
3
FEI number
3005080452

In short: On February 17, 2026, FDA issued a Form 483 with 1 observation to Blood Assurance Inc in Tullahoma, Tennessee (FEI 3005080452) after an inspection that ran Feb 17, 2026. The investigator was Cody D. Rickman. Most observations concern biologics CGMP; the most-cited regulation is 21 CFR 630.10 (general donor eligibility requirements).

At a glance

1 of 1 observations on this 483 concern biologics cgmp.

Biologics CGMP1

Most cited: 21 CFR 630.10 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Blood or blood components were collected from a donor found to be ineligible prior to collection…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Blood Assurance Inc?

FDA listed 1 observation on this Form 483, mostly about biologics CGMP. The most-cited regulation is 21 CFR 630.10 (general donor eligibility requirements). The opening words of each observation are shown on this page.

Who inspected Blood Assurance Inc?

Cody D. Rickman is named on this Form 483, for the inspection of Feb 17, 2026. Each investigator has a profile showing what they cite most.

When was Blood Assurance Inc inspected by FDA?

The inspection ran Feb 17, 2026, and the Form 483 is dated February 17, 2026.

How do I get the full Form 483 for Blood Assurance Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free